X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-02-23 | PRTA | Ecor1 Capital, LLC | 10% | P - Purchase | $21.24 | +55,200 | 10,159,280 | +1% | +$1,172,385 | |||||
| A | 2021-02-18 | PRTA | Ecor1 Capital, LLC | 10% | P - Purchase | $23.65 | +44,100 | 10,104,080 | 0% | +$1,043,075 | |||||
2021-02-18 | PRTA | Ecor1 Capital, LLC | 10% | P - Purchase | $3.68 | +44,100 | 10,104,080 | 0% | +$162,103 | ||||||
| D | 2021-02-18 | PRTA | Zago Wagner M. | Chief Scientific Officer | S - Sale+OE | $25.50 | -7,540 | 0 | -100% | -$192,270 | |||||
| DM | 2021-02-12 | PRTA | Ecor1 Capital, LLC | 10% | P - Purchase | $21.56 | +633,340 | 10,059,980 | +7% | +$13,657,270 | |||||
| D | 2021-02-12 | PRTA | Zago Wagner M. | Chief Scientific Officer | S - Sale+OE | $19.16 | -26,310 | 0 | -100% | -$504,057 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |